MACUSAN
ActiveSummary
MACUSAN has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €193k and a net result of €163k. Its solvency ranks better than 77% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+15
Growth78
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days only on tighter terms
Liquidity ample (current ratio 7.09 against 2.48 in 2024; short-term debt: 14.1% and cash: 75.4% of total assets), and 14.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
85.9%
Return on assets
73%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
24 d early
2024
90 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€193k▲ 543%
2024 · €30k
2024: €30k
2025: €193k▲ +543% vs 2024
2024 → 2025
Total assets
€224k▲ 347%
2024 · €50k
2024: €50k
2025: €224k▲ +347% vs 2024
2024 → 2025
Net result
€163k▲ 449%
2024 · €30k
2024: €30k
2025: €163k▲ +449% vs 2024
2024 → 2025
Working capital
€192k▲ 541%
2024 · €30k
2024: €30k
2025: €192k▲ +541% vs 2024
2024 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€30k-€193k▲ 543%
2024: €30k
2025: €193k▲ +543% vs 2024
Operating result€37k-€214k▲ 473%
2024: €37k
2025: €214k▲ +473% vs 2024
Net result€30k-€163k▲ 449%
2024: €30k
2025: €163k▲ +449% vs 2024
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2025; 2025 is 473% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €224k
Fixed assets
€809
Current assets
€223k
Equity and liabilities €224k
Equity
€193k ▲ 543%
Debt
€31k ▲ 56.0%
Debt's share of the balance-sheet total falls from 40.3% to 14.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€214k
Cash flow
€164k
Current ratio
7.09▲
2024 · 2.48
Debt to equity
0.16▼
2024 · 0.67
ROE
84.9%▼
2024 · 99.4%
ROA
73.0%▲
2024 · 59.4%
Interest coverage
4643.60
Debt ≤ 1 year
€31k▲
2024 · €20k
Income taxes
€51k▲
2024 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet
Code20242025
Assets
Total assets20/58€50k€224k▲
Fixed assets21/28-€809
Tangible fixed assets22/27-€809
Furniture and vehicles24-€809
Current assets29/58€50k€223k▲
Amounts receivable within one year40/41€48k€48k▲
Trade receivables40€48k€44k▼
Other amounts receivable41-€4k
Cash at bank and in hand54/58€3k€169k▲
Deferred charges and accrued income490/1-€7k
Equity and liabilities
Total equity and liabilities10/49€50k€224k▲
Equity10/15€30k€193k▲
Contributions10/11€1k€1k=
Profit (loss) carried forward14€29k€192k▲
Amounts payable17/49€20k€31k▲
Amounts payable within one year42/48€20k€31k▲
Trade debts44€187€79▼
Suppliers440/4€187€79▼
Taxes, remuneration and social security45€8k€31k▲
Taxes450/3€8k€31k▲
Other amounts payable47/48€12k€583▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€315
Other operating charges640/8-€149
Gross operating margin9900€37k€214k▲
Operating profit (loss)9901€37k€214k▲
Financial income75/76B-€112
Recurring financial income75-€112
Financial charges65/66B€4€46▲
Recurring financial charges65€4€46▲
Profit (loss) for the period before taxes9903€37k€214k▲
Income taxes67/77€8k€51k▲
Profit (loss) for the period9904€30k€163k▲
Profit (loss) for the period to be appropriated9905€30k€163k▲
Appropriation of the result
Profit (loss) to be appropriated9906€30k€192k▲
Profit (loss) brought forward from the previous period14P-€29k
Profit to be distributed694/7€833€833=
Return on contributions (dividend)694€833€833=
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €315 | - |
| Other operating charges640/8 | - | €149 | - |
| Gross operating margin9900 | €37k | €214k | ▲ 474% |
| Operating profit (loss)9901 | €37k | €214k | ▲ 473% |
| Financial income75/76B | - | €112 | - |
| Recurring financial income75 | - | €112 | - |
| Financial charges65/66B | €4 | €46 | ▲ 1,131% |
| Recurring financial charges65 | €4 | €46 | ▲ 1,131% |
| Profit (loss) for the period before taxes9903 | €37k | €214k | ▲ 473% |
| Income taxes67/77 | €8k | €51k | ▲ 567% |
| Profit (loss) for the period9904 | €30k | €163k | ▲ 449% |
| Profit (loss) for the period to be appropriated9905 | €30k | €163k | ▲ 449% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €50k | €224k | ▲ 347% |
| Fixed assets21/28 | - | €809 | - |
| Tangible fixed assets22/27 | - | €809 | - |
| Furniture and vehicles24 | - | €809 | - |
| Current assets29/58 | €50k | €223k | ▲ 345% |
| Amounts receivable within one year40/41 | €48k | €48k | ▲ 0.4% |
| Trade receivables40 | €48k | €44k | ▼ 8.3% |
| Other amounts receivable41 | - | €4k | - |
| Cash at bank and in hand54/58 | €3k | €169k | ▲ 6,386% |
| Deferred charges and accrued income490/1 | - | €7k | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €50k | €224k | ▲ 347% |
| Equity10/15 | €30k | €193k | ▲ 543% |
| Contributions10/11 | €1k | €1k | = |
| Profit (loss) carried forward14 | €29k | €192k | ▲ 562% |
| Amounts payable17/49 | €20k | €31k | ▲ 56.0% |
| Amounts payable within one year42/48 | €20k | €31k | ▲ 56.0% |
| Trade debts44 | €187 | €79 | ▼ 57.5% |
| Suppliers440/4 | €187 | €79 | ▼ 57.5% |
| Taxes, remuneration and social security45 | €8k | €31k | ▲ 294% |
| Taxes450/3 | €8k | €31k | ▲ 294% |
| Other amounts payable47/48 | €12k | €583 | ▼ 95.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €30k | €163k | ▲ 449% |
| + Depreciation and write-downs630 | - | €315 | - |
| Operating cash flow (approximation) | €30k | €164k | ▲ 450% |
| Change in cash | - | €166k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Liquidity triplescurrent ratio 7.09
Current ratio from 2.48 to 7.09.
31-12
Financial
Equity above €150kEq €193k ▲543%
2 profitable years in a row build equity to €193k.
02-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2024
Ground area
236 m²
Building footprint
139 m²
Volume, LiDAR
2,069 m³
Parcel 21443C0201/00Y014, Brussels · tallest building 17.4 m, ±5 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
MACUSAN
since 20242.366.259.174
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21443C0201/00Y014 | Brussels | 236 m² | 1 · 139 m² | 17.4 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Société médicale Vinciane Laret
BE 0823.387.270
Liège · Eq €192,616
STEPHANIE HOSTENBACH NEUROLOGIE
BE 0772.877.489
Gent · Eq €192,463
GYN&FORM
BE 0780.434.086
Esneux · Eq €192,718
Maxime Bonnelance Ortho
BE 0739.548.487
La Hulpe · Eq €192,343
DR. TOM BLOOTACKER
BE 0890.043.888
Jodoigne · Eq €192,840
Of 16,630 companies in sector 86220 we hold annual accounts for 7,979. 6,739 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded12-11-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.